Loading...
Efficacy and Safety of Combination Therapy Consisting of Angiotensin II Type 1 Receptor Blocker, Calcium Channel Blocker and Hydrochlorothiazide in Patients With Hypertension
BACKGROUND: Many patients continue to have high blood pressure (BP) even after treatment with high-dose (H)-angiotensin II type 1 receptor blocker (ARB)/calcium channel blocker (CCB) or middle-dose (M)-ARB/CCB/hydrochlorothiazide (HCTZ). METHODS: Thirty-two hypertensive patients who had the use of H...
Na minha lista:
| Udgivet i: | J Clin Med Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elmer Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215013/ https://ncbi.nlm.nih.gov/pubmed/28090225 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2838w |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|